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Mice homozygous for the viable motheaten (mev) allele manifest abnormalities in
thymocytopoiesis, are severely immunodeficient, and develop autoimmune disorders
early in life. Premature thymic involution occurs in meV/me mice, and their bone marrow
prothymocytes are unable to repopulate the thymus of adoptive recipients following
intravenous (i.v.) transfer. However, analysis of thymocytopoiesis following intrathymic
(i.t.) adoptive transfer of bone marrow from meV/me mice demonstrates the presence of
normal numbers of prothymocytes. To investigate intrathymic development in meV/me
mice, we determined intrathymic precursor cell number and activity. Dual labeling
analyses showed that an involuted meV/me thymus is relatively enriched (fivefold) in
CD4-CD8- thymocytes (intrathymic precursor phenotype) compared with wild-type
(+/+) thymus. However, thymocytes from meV/me mice were deficient in precursor
activity when adoptively transferred i.t. into irradiated recipients. Thymocytes
recovered from the involuted thymus of aged or steroid-treated normal mice also
displayed reduced precursor activity. However, the phenotypic profile of thymocyte
subsets from steroid-treated mice was enriched in single positive cells (mature
phenotype) and was distinctly different from the subset distribution of thymocytes in
meV/me and aged mice. These results suggest that intrathymic precursor activity in
me/me mice is decreased, and may be reflective of decreased prothymocyte seeding to
the thymus in vivo, In addition, the results suggest that the thymic involution in meV/me
mice is not due solely to effects of corticosteroids.
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INTRODUCTION
Mice homozygous for the motheaten (me) or
viable motheaten (mev) alleles display numerous
defects in lymphopoiesis. These defects include a
paucity of surface immunoglobulin-positive (Ig/)
B cells and abnormal peripheral T-cell functions
(Green and Shultz, 1975; Shultz et al., 1984;
Greiner et al., 1986; Shultz and Sidman, 1987;
Shultz, 1988). Furthermore, a number of auto-
immune disorders develop that include hyper-
gamma-globulinemia, autoantibody production,
and immune complex glomerulonep,hritis
(Kincade, 1981; Shultz and Sidman, 1987; Shultz,
1988). The usual cause of death is a characteristic
hemorrhagic macrophagic pneumonitis that is
*Corresponding author. Present address: The Jackson
Laboratory, Bar Harbor, Maine 04609.
believed to be autoimmune in origin (Shultz and
Sidman, 1987; Shultz, 1988). This autoimmune
syndrome can be transferred to irradiated recipi-
ents using meV/me bone marrow stem cells
(Kincade, 1981; Shultz, 1988).
Developmental abnormalities are evident in
cells that express the enzyme terminal deoxy-
nucleotidyl transferase (TdT; presumptive T- and
B-lymphoid stem cells) in me and me"/me
bone marrow and thymus (Landreth et al., 1981;
Greiner et al., 1986). These bone marrow and thy-
mus TdT/-cell developmental defects appear to
be associated with the defects in thymocyto-
poiesis and may have a causal relationship to the
peripheral T- and B-lymphocyte abnormalities.
Moreover, at least some of the TdT/- (Landreth et
al., 1981; Greiner et al., 1986) and B-cell progeni-
tor cell (McCoy et al., 1985; Greiner et al., 1986;
Kincade, 1987) developmental abnormalities,
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when analyzed in selective in vitro assay systems
(Medlock et al., 1987; Hayashi et al., 1988),
appear to be secondary to bone marrow micro-
environmental defects.
Studies on thymocytopoiesis in me and
meV/me mice have demonstrated a premature
thymic involution, commencing as early as 4
weeks of age (Greiner et al., 1986; Shultz and Sid-
man 1987; Shultz, 1988). Furthermore, we have
shown that bothme and meV/me bone marrow
prothymocytes fail to repopulate the thymus of
irradiated recipients after intravenous (i.v.)
transfer, but generate normal numbers of thymo-
cytes following intrathymic (i.t.) adoptive trans-
fer (Greiner et al., 1986). Mixing of meV/me bone
marrow with normal bone marrow restores the
ability of meV/me prothymocytes to generate thy-
mocytes after i.v. injection (Komschlies et al.,
1987), again suggesting that a marrow micro-
environmental defect may underlie certain of the
early developmental defects observed in lympho-
poiesis in me/me and meV/me mice.
The apparent prothymocyte homing defect in
me and meV/me bone marrow cells may have
in vivo consequences, since postnatal mainten-
ance of normal thymocytopoiesis is dependent
upon a low, but continual, seeding of the thymus
by bone marrow hemopoietic precursors (Scollay
and Shortman, 1984; Scollay et al., 1986). Further-
more, the ability of bone marrow precursors to
generate thymoc}tes following entry into the
thymus appears to be self-limiting, and will cease
within 4 to 5 weeks following thymic entry
(Goldschneider et al., 1986; Scollay et al., 1988).
Because me and meV/me bone marrow pro-
thymocytes appear to be unable to repopulate
the thymus of irradiated recipients following
i.v. transfer, we have postulated that this defect
may result in an early loss of intrathymic pre-
cursors in me and meV/me mice, leading to
premature thymic involution (Greiner et al.,
1986; Komschlies et al., 1987).
We have investigated this hypothesis in the
present study using the i.t. adoptive transfer
assay to quantitate directly the intrathymic pre-
cursor activity prior to and during thymic invol-
ution in meV/me mice. Our results indicate that
the pool of intrathymic precursors in meV/me
mice decreases early in life, in association with
the onset of thymic involution. Furthermore, the
thymic involution observed in meV/me mice does
not appear to be similar to that induced follow-
ing administration of corticosteroids.
RESULTS
Phenotypic Characteristics of me’/me
Thymocytes During Thymic Involution
Investigations of murine thymocyte subpopu-
lations have revealed a large diversity of cell sub-
sets (Scollay et al. 1988; Wilson et al., 1988). Four
major phenotypic populations have been exten-
sively characterized, and are identified as
CD4-CD8- (double negative, DN), CD4/CD8
/
(double positive, DP), and CD4/CD8 or
CD4-CD8
/ (single positive, SP). Because the thy-
mus of meV/me mice has been shown to undergo
premature thymic involution, commencing as
TABLE
Subpopulations of Thymocytes in Various Ages of C57BL/6J-me’/me Mice
Genotype Thymus Animal
cell number age
(x10-6) (weeks)
Thymocyte subpopulations
CD4-CD8- CD4/CD8 CD4/CD8 CD4-CD8/(%)
(%) (%) (%)
me"/me 1.6 7 31.3 33.1 7.5 27.5
3.8 6 15.8 48.7 15.8 19.7
9.0 4 24.4 43.2 21.8 10.8
13.0 4 14.0 47.8 28.3 9.9
58.0 5 5.5 69.4 15.3 15.3
72.5 4 11.6 65.0 15.7 7.6
135.0 5 8.7 71.7 13.0 6.9
150.0 4 4.0 88.7 5.0 2.2
270.0 4 4.1 85.1 8.1 2.8
Wild-type (+/+) 285.0+37.7 4 3.9+0.1 80.7+1.3 9.4+0.4 6.0+0.9
’Thymocytes from various aged C57BL6J-me’/me mice analyzed for expression of CD4 and CD8 antigens using two-color immunofluorescence staining (see
Materials and Methods). Data represent individual me"/me thymuses except for the C57BL/6J+/+ data that represent the percentage+standard deviation for three
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early as 4 weeks of age (Greiner et al., 1986;
Shultz and Sidman, 1987; Shultz, 1988), we exam-
ined the phenotypic characteristics of the thymo-
cytes prior to and during this involution process.
As shown in Table 1 and Figure 1B, the loss of
cellularity in the meV/me thymus is evident as
early as 4 weeks of age compared with untreated
control B6+/+ mice. The loss of cellularity, vari-
able between 4 and 7 weeks of age, is
accompanied bya loss in the absolute numbers of
DN, DP, and SP thymocytes compared with
weanling B6 wild-type mice, with losses of 95%,
99.5%, and 98.4%, respectively, in the most
severely involuted thymuses. The relative pro-
portions of each unique thymocyte subset, how-
ever, were not as severely altered (Fig. 1B). There
was a relative increase in the proportion of DN
thymocytes in the most severely involuted thy-
mus, approaching 30% of the total thymocyte
population as compared to that of approximately
5% DN cells in the thymus of control B6+/+
mice. In the severely involuted thymuses (less
than 13x106 total thymocytes), the DP and SP
populations were approximately equal, each
comprising 33-49% of the remaining cells pre-
sent, whereas in normal B6+/+ mice, the DP and
SP populations normally comprise approxi-
mately 80% and 15%, respectively, of a thymo-
cyte population (Scollay et al., 1988). However,
during the involution process, as thymus cellu-
larity decreased, but prior to the most severely
involuted state, the relative proportions of each
B -..=
FIGURE Dual labeling analysis of normal and involuted thymuses with anti-CD4 and anti-CD8 monoclonal antibodies. (A)
Normal thymus with a cellularity of 250106 cells. Percentage of thymocytes in each quadrant: (CD4/CD8"), 10.5%; 2
(CD4+CD8/), 81.3%; 3 (CD4-CD8-), r.4%; and 4 (CD4-CD8/), 4.8%. (B) Involuted me"/me thymus with a cellularity of 13x106 cells.
Percentage of thymocytes in each quadrant: 1, 28.3%; 2, 47.8%;.3, 14.0%; and 4, 9.9%. (C) Involuted thymus from an 18-month-old
normal B6 wild-type mouse with a cellularity of 42106 cells. Percentage of thymocytes in each quadrant: 1, 9.0%; 2, 83.9%; 3,
3.9%; and 4, 3.2%. (D) Involuted thymus with a cellularity of 8x106 cells from a steroid-treated 4-week-old normal B6 mouse.
Percentage of thymocytes in each quadrant: 1, 50.9%; 2, 12.3%; 3, 17.4%; and 4, 19.4%.194 S.M. HAYES et al.
of the major thymocyte subsets approximated
that observed in normal mice (Table 1).
Intrathymic Precursor Activity of me’/me
Thymocytes During Thymic Involution
The relative proportion of DN thymocytes was
increased in the involuted meV/me thymus (Table
1 and Figure 1B), although the absolute number
of DN thymocytes was decreased (Table 1). The
increased percentage of DN thymocytes may be
reflective of a compensatory enrichment in intra-
thymic precursors (i.e., DN thymocytes that pos-
sess the ability to repopulate the thymus of
irradiated recipients upon adoptive transfer).
Alternatively, the DN thymocytes remaining in
the involuted thymuses of meV/me mice may be
CD3
/ DN thymocytes with no precursor activity
upon adoptive transfer (Scollay et al., 1988). To
investigate these various possibilities, we used
the i.t. adoptive transfer assay (Goldschneider et
al., 1986; Scollay et al., 1988; Shortman et al.,
1988) to quantitate the intrathymic precursor
activity of thymocytes in meV/me mice. This assay
system was used because intrathymic precursors
poorly repopulate the thymus following i.v.
adoptive transfer (Kadish and Basch, 1977;
Fowlkes et al., 1985; Scollay et al., 1988),.and
intrathymic precursor activity is readily quant-
ified using the ,i.t. adoptive transfer assay
(Goldschneider et al., 1986; Scollay et al., 1988).
Thymocytes recovered from meV/me mice with
involuted thymuses were relatively deficient, on
a per cell basis, in their ability to repopulate the
thymus of adoptive recipients as compared to
thymocytes recovered from B6+/+ mice. The i.t.
transfer of 1.2 to 1.9x106 thymocytes from meV/me
mice with 2.1+1.0x106 cells/thymus resulted in
the generation of <1x106 (nondetectable) (n=6)
donor-origin cells on day 14, and the transfer of
1x106 or 2.5x106 thymocytes from B6+/+ mice
resulted in the generation of 3.9+1.0x106 (n=4)
and 8.0+4.3x106 (n=3) donor-origin cells, respect-
ively, on day 14. In addition, it was of interest to
compare the "total" precursor population in the
thymus of meV/me mice with that Of normal
B6+/+ mice during the involution process. To
compare this directly, the relative intrathymic
precursor activity of each thymus, which takes
into account the total cellularity of the thymus,
hence the total precursor pool within the thymus,
was calculated (see Materials and Methods).
Thymocytes from 4-week-old me’/me mice
clustered into two distinct groups when the rela-
tive intrathymic precursor activity was calcu-
lated (Fig. 2A). In one group, the relative intra-
thymic precursor activity was equivalent to that
of age-matched B6+/- littermates. In" the second
group, the relative intrathymic precursor activity
was decreased in relation to that of B6+/- litter-
mates (Fig. 2A). In 5-, 6-, and 7-week-old meV/me
mice, the relative intrathymic precursor activity
was reduced in relation to that of age-matched
B6+/- littermates, approaching nondetectable
levels of precursor activity in 60% (3/5) of 6-
week-old meV/me mice and 100% (3/3) of
7-week-old meV/me
v mice. No differences were
observed in the relative intrathymic precursor
activity of B6+/- littermates between 4 and 7
weeks of age (Fig. 2A), which, as observed in
bone marrow prothymocyte activity (Komschlies
et al., 1987), were comparable to that of wild-type
B6+/+ mice (data not shown). Furthermore, in
3-week-old meV/me mice, we observed a decrease
in intrathymic precursor activity prior to detect-
able thymic involution, suggesting that the loss
of intrathymic precursor activity precedes thymic
involution (data not shown).
Due to the variability in intrathymic precursor
activity observed in involuting meV/me thymuses,
especially in 4-week-old meV/me mice, we deter-
mined whether the extent of thymic involution in
meV/me mice (loss in total cellularity) was related
to the level of intrathymic precursor activity. As
shown in Fig. 2B, there is a strong linear corre-
lation (r2=0.872) between the cellularity of the
meV/me thymus and the relative intrathymic pre-
cursor activity detectable during involution; as
thymic cellularity decreased, the amount of
intrathymic precursor activity correspondingly
decreased.
Phenotypic Characteristics of Thymocytes in
Aged B6 Wild-Type Mice During Thymic
Involution
Motheaten (me and meV/me mice have
expected lifespans of 22 and 61 days, respectively
(Shultz and Sidman, 1987; Shultz, 1988), and we
have previously suggested (Medlock et al., 1986)
that these mice may be representative of an accel-
erated aging process in the immune system.
Therefore, it was of interest to compare directlyTHYMOCYTOPOIESIS IN me"/me MICE 195
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FIGURE 2 Thymocytes from meV/me and age-matched B6+/- littermate mice (Ly 5.2) were tested for precursor activity
following intrathymic adoptive transfer into irradiated B6-Ly5.1 congenic recipients. Relative intrathymic precursor.activity was
calculated as described (see Materials and Methods). Values represent data from individual thymuses. (A) Relative intrathymic
precursor activity normalized to that of control B6+/- littermates as a function of age. Open squares represent me’/md thymuses
and x’s represent age-matched B6+/- littermate thymuses. (B) Relative intrathymic precursor activity as a function of thymus
cellularity (r2=0.872).
the thymic involution of meV/me mice with that
observed in normal mice during aging.
As observed in an meV/me involuting thymus,
there is a significant decrease in the absolute
number of each of the four major thymocyte sub-
sets (DN, 76%; DP, 92%; SP, 80%) in the severely
involuted thymuses from aged normal mice as
compared to thymocyte subsets present in wean-
ling (4-6-week-old) B6+/+ mice (Table 2). How-
ever, the relative proportion of each of the major
thymocyte subsets was consistent in aging B6+/+
mice through 14-15 months of age, although the
cellularity of the older 14-16-month thymuses
was decreased 60 to 90% with respect to that of
weaning B6+/+ mice (Table 2). The staining pro-
file of a typical older thymus (cellularity of 42x
106) is shown in Fig. 1C.
Intrathymic Precursor Activity of Thymocytes
in Aged Mice During Thymic Involution
Thymocytes from weanling (1-month-old) B6+/+
mice were comparable to that of weanling B6+/-
littermate mice in intrathymic precursor activity
(Figs. 2A and 3A). By 11 to 13 months of age,
however, the intrathymic precursor activity of
B6+/+ mice was decreased by 57 to 87% as com-
pared to that of 1-month-old B6+/+ mice and
continued to decrease with time to essentially
nondetectable levels (98% decrease) of intra-
thymic precursor activity in 100% (4/4) of 16-17-
month-old mice (Fig. 3A). As observed in involu-
ting meV/me thymuses, the decrease in thymus
cellularity exhibited a strong linear correlation
(r2=0.900) with the loss of intrathymic precursor
activity with age (Fig. 3B).
Prothymocyte Activity in the Bone Marrow of
Aged Mice
Viable motheaten (meV/mev) mice with severely
involuted thymuses still contain normal numbers
of bone marrow prothymocytes as quantitiated
by the i.t. adoptive transfer assay system, but no
detectable intrathymic precursor activity
(Greiner et al., 1986; Komschlies et al., 1987; Fig.
2). Therefore, we determined whether the loss of
intrathymic precursor activity in B6+/+ aged196 S.M. HAYES et al.
TABLE 2
Effect of Age on Subpopulations of Thymocytes in C57BL/6J+/+ Mice
Thymus Animal
cell number age
(xl0
-6 (months)
Thymocyte subpopulations
CD4-CD8- CD4/CD8 CD4/CD8 CD4-CD8
(%) (%) (%) (%)
18 15 4.8 71.7 15.1 5.8
20 14 3.6 76.0 15.1 3.8
23 18 11.6 43.6 19.6 12.5
42 18 1.8 84.3 8.8 3.6
43 12 2.5 87.2 8.0 2.1
53 18 4.7 77.1 13.5 4.7
60 3 3.1 81.3 10.9 3.6
60 14 4.8 73.4 14.3 5.8
67 12 3.3 86.3 7.3 3.1
72 15 4.0 77.4 12.8 4.9
77 8 3.9 76.9 14.1 4.2
108 8 4.1 78.2 12.5 4.1
110 12 3.9 83.9 9.0 3.3
175 3 3.3 82.9 10.0 3.6
181.7+10.4 3.2+0.7 83.2+3.0 9.0+1.4 4.5+1.2
aThymocytes from various aged C57BL/6J+/+ mice analyzed for expression of CD4 and CD8 antigens using two-color immunofluorescence staining (see Materials
and Methods). Data represent individual thymuses except for the 1-month-old group that represents the percentage+standard deviation of three individual thymuses.
bThe percentage of the CD4-CD8- subset excludes sIg cells in the thymus.
mice is associated with a decrease in bone mar-
row prothymocyte activity. Bone marrow was
recovered from 12-month-old B6+/+ mice (57 to
87% decrease in intrathymic precursor activity)
and injected both i.v. and i.t. into young (4-6-
week-.old) irradiated adoptive recipients to deter-
mine their relative bone marrow prothymocyte
activity. As shown in Table 3, in contrast to that
observed in meV/me mice and as shown pre-
viously by other investigators (Hirokawa et al.,
1986), the bone marrow of aged mice is able to
repopulate the thymus of young adoptive recipi-
ents following i.v., as well as i.t., adoptive trans-
fer. Furthermore, on a per cell basis, bone mar-
row from 1-year-old donors does not differ
significantly from that of weanling (1-month-old)
bone marrow in relative prothymocyte activity.
For the i.v. adoptive transfer system, the relative
prothymocyte activity is 219+109 (mean+S.D.)
units for young donors and 421+147 units for
aged ones. Similar results are observed for the i.t.
adoptive transfer system in which the relative
prothymocyte activity is 10,410+7,563 units for
young bone marrow and 16,245+8,189 units for
aged marrow.
To investigate further the possible mechanisms
that account for thymic involution in aged mice,
especially since bone marrow precursor activity
in older mice is comparable to that of young mice
(Table 3), we determined the ability of young and
older (12-month-old) bone marrow to repopulate
the thymuses of older (10-month-old) irradiated
recipients. Surprisingly, there were no significant
differences (p>0.1 for the i.v. assay; p>0.5 for the
i.t. assay) in the number of thymocytes generated
by either young or old marrow on a per cell basis
in older recipients as compared to that of young
recipients. The relative prothymocyte activities
calculated for both adoptive transfer assays are
477+127 units (i.v.) and 15,912+3,917 units (i.t.)
for young bone marrow and 372+58 units (i.v.)
and 14,070+9,478 units (i.t.) for aged marrow.
Phenotypic Characteristics of Thymocytes in
Corticosteroid-Treated Mice Following Thymic
Involution
To investigate whether the thymic involution
observed in meV/me mice resembled that of
corticosteroid-induced thymic involution, nor-
mal B6+/+ mice were injected with dexa-
methasone (0.5 mg), and the thymus analyzed
48 h later. Steroid treatment resulted in a 97%
decrease in cellularity, and a decrease in the
absolute numbers of each of the four major
thymocyte subsets (Table 4). The proportions of
each of the thymus subsets that were present,
however, were different (Fig. 1D) from that
observed in an meV/me involuted thymus (Fig.
1B). The proportion of DN thymocytes increased
to 19.3+3.1%, similar to that of meV/me thymo-
cytes (range 5.5-32%), but the percentage of DPTHYMOCYTOPOIESIS IN meV/me MICE 197
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FIGURE 3 Thymocytes from 1-, 11-13-, and 16-17-month-old normal B6+/+ mice (Ly5.2) were tested for precursor activity
following intrathymic adoptive transfer into irradiated B6-Ly5.1 congenic recipients. Relative intrathymic precursor activity was
calculated as described (see Materials and Methods). Values represent data from individual thymuses. (A) Relative intrathymic
precursor activity as a function of age normalized to that of control 4-week-old B6+/+ mice. (B) Relative intrathymic precursor
activity as a function of thymus cellularity (r2=0.900).
TABLE 3
Effect of Age on Bone Marrow Prothymocyte Activity
in C57BL/6J+/+ Mice
Age of Age of Rdute
donor recipient of
(months) (months) injection
Donor-origin thymocytes
Percentage Cells/thymus
(xl0-6)
i.t. 67.8+18.7 90.5+65.8
12 i.t. 85.2+11.0 81o2+40.9
10 i.t. 86.4+4.6 146.3+36.0
12 10 i.t. 78.4+12.3 112.6+75.8
i.v. 73.2+10.6 95.5+47.4
12 i.v. 82.1+_5.2 105.3+_36.9
10 i.v. 94.7+_0.9 216.3+_54.1
12 10 i.v. 89.5+_6.2 148.9+_23.2
aBone cells from young (1-month-old) and aged (12-month-old) mice
injected i.t. (0.2x106) i.v. (10x106) into irradiated young (1-month-old)
aged (10-month-old) B6+/+ recipients. Twenty days post injection, thymuses
recovered and analyzed for donor-origin thymocytes using the indirect
immunofluorescence staining technique (see Materials and Methods). Data
represent mean+standard deviation for three animals per group.
thymocytes (10.4+3.4%) was decreased relative to
involuted meV/me thymocytes (range 33-72%),
and SP thymocytes were the predominant thym-
ocyte subset (65.8+5.4%) in steroid-treated mice
(Table 4 and Fig. 1D).
Intrathymic Precursor Activity of Thymocytes
in Steroid-Treated Mice
Thymocytes recovered from steroid-treated
B6+/+ mice were tested for their intrathymic pre-
cursor activity in the i.t. adoptive transfer assay.
The thymocyte repopulating activity of steroid-
treated thymocytes (1.1+0.1 units) was decreased
more than 99% when compared to the relative
thymocyte repopulating activity of age-matched
untreated B6+/+ (392.2+185.8 units) mice.
Prothymocyte Activity in the Bone Marrow of
Steroid-Treated Mice
The high sensitivity of intrathymic precursors to
steriods was surprising in light of previously
published results detailing the relative steroid
resistance of bone marrow prothymocytes
(Greiner et al., 1982). To confirm this result, bone
marrow cells were recovered from the same
steriod-treated mice that were used as donors of
thymocytes (see Table 4), and were injected both
i.t. and i.v. into adoptive recipients. As expected,
on a per cell basis and as previously reported198 S.M. HAYES et al.
TABLE 4
Dexamethasone Sensitivity of Thymocyte Subpopulations in C57BL/6J+/+ Mice
Dexamethasone Thymus
treatment cell number
(10
-6
Thymocyte subpopulations
CD4-CD8- CD4+CD8 CD4/CD8 CD4-CD8
(%) (%) (%) (%)
+ 7.5+4.1 19.3+3.1b 10.4+3.4 48.1+4.6 17.8+3.8
173.3+10.4 3.0+0.6 82.4+3.9 10.1+2.1 4.5+1.2
aFour-week-old C57BL/6+/+ mice injected with dexamethasone (0.5 mg) and the thymuses recovered for analysis 48 h later. Thymocytes from these mice
analyzed for expression of CD4 and CD8 antigens using two-color immunofluorescence staining (see Materials and Methods). Data represent the percentage+standard
deviation for four mice in the dexamethasone-treated group and for three mice in the untreated group.
bThe percentage for CD4-CD8- thymocytes excludes surface Ig cells in the thymus.
(Greiner et al., 1982), the number of thymocytes
generated by equivalent doses of untreated and
steroid-treated bone marrow was essentially
equal (Table 5). However, because the cellularity
of the steroid-treated bone marrow was reduced
approximately 60%, the total number of pro-
thymocytes in steroid-treated marrow was
approximately 40% of that of normal marrow.
Although variable, when the same bone marrow
was analyzed by the i.t. assay, similar results
were observed. By using a standard cell dose of
2.0x105 cells/recipient, the total prothymocyte
activity per leg (femur plus tibia) detectable in
the marrow of steroid-treated mice was approxi-
mately 30% of that of untreated mice (Table 5).
Expression of CD3 and Surface
Immunoglobulin in the DN Population
The DN thymocyte population is the only thymo-
cyte subset demonstrated to be able to repopulate
the thymus of adoptive recipients in both the i.v.
and i.t. adoptive transfer systems (Scollay et al.,
1988). However, CD4-CD8- thymocytes that
express CD3 do not generate thymocytes upon
i.t. injection into adoptive recipients (Crispe et
al., 1987; Scollay et al., 1988; Shortman et al.,
1988). In addition, approximately 1% of cells in
the normal thymus are surface Ig
/ B lymphocytes
(Andreu-Sanchez et al., 1990). Surface Ig
/ cells
could be contaminants in the DN (CD4-CD8-)
population, and would also fail to generate
thymocytes upon i.t. adoptive transfer into
irradiated recipients. Therefore, DN thymocytes
that expressed either CD3 or sIg were quantit-
ated in the thymus of normal B6+/+ 4-6-week
mice as well as in involuted thymuses (Table 6).
Even though the percentage of DN thymocytes is
greater in the severely involuted thymuses (<25x
106 thymocytes), the proportion of CD3
/ or sIg
/
DN cells approximates that observed in normal
thymuses (approximately 50%).
DISCUSSION
In the present study, we have demonstrated that
meV/me involuted thymuses display a loss in all
four of their major phenotypic thymocyte subsets
(DN, DP, SP) by 4 to 7 weeks of age. Prior to this
loss of thymocytes, a decrease in the intrathymic
precursor activity was observed. This decrease
was evident as early as 3 weeks of age in meV/me
mice whose thymuses have not lost cellularity.
At 4 weeks of age,, approximately half of the
meV/me mice examined had reduced intrathymic
precursor activity, and the majority of the ani-
mals studied at 6 to 7 weeks of age demonstrated
reduced activity. Although a relative increase in
the percentage of DN thymocytes was observed
TABLE 5
Dexamethasone Sensitivity of Bone Marrow Prothymocytes
in C57BL/6J+/+ Mice
Route Dexamethasone
of injection treatment
Number of
donor-origin
thymocytes
(xl0)
Relative
bone marrow
prothymocyte
activity/
femur+tibia
(X10-6)
i.v. 52.7+22.6 178
i.v. + 45.4+21.1 66
i.t. 111.8+78.6 18,894
i.t. + 80.4+42.3 5,869
aFour-week-old C57BL/6J+/+ mice injected with dexamethasone (0.5 mg)
and the thymuses recovered 48h later. Bone cells from
dexamethasone and untreated mice injected i.t. (0.2x106) i.v. (10x106) into
irradiated B6 Ly congenic recipients. Twenty days post injection, thymuses
recovered and the percentage of donor-origin thymocytes determined by
indirect immunofluorescence staining (see Materials and Methods). Data represent
the mean+standard deviation for three mice per group.
bRelative bone prothymocyte activity calculated follows: number
of donor-origin thymocytes divided by the number of cells injected times the total
number of donor bone cells per leg (femur plus tibia) (see Materials and
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in the involuting thymus of meV/me mice, there
was a decrease in the absolute number of DN
cells relative to that of normal age-matched
B6+/+ mice. Because only DN thymocytes are
able to generate the other three phenotypic
thymocyte subsets (DP and SP) in vivo in adop-
tive recipients (Scollay et al., 1988; Shortman et
al., 1990), our observations would suggest that
the intrathymic precursors, although reduced in
absolute numbers, may be relatively enriched in
involuting meV/me thymuses. However, the DN
thymocytes that were present in the severely
involuted meV/me thymuses were deficient in
their ability to generate thymocytes upon trans-
fer to irradiated adoptive recipients.
It has been calculated that as few as lx103 puri-
fied DN thymocytes can generate detectable
levels of donor-origin thymocytes in an
irradiated recipient’s thymus, while up to 6x105
DN thymocytes (2x107 unfractionated thymo-
cytes) are required for saturation repopulation of
the thymus of an irradiated recipient (Scollay et
al., 1988). We injected in our experiments at least
5x105 thymocytes from each involuted thymus
into the irradiated recipient’s thymus. Because,
in the severely involuted thymus, at least 20% of
the thymocytes were DN (Table 1), at least
100,000 DN cells were injected into the thymus of
each of the adoptive recipients. Our failure to
find evidence of intrathymic precursor activity
following injection of approximately 100-fold
more DN thymocytes than should have been
necessary to generate thymocytes in adoptive
recipients (and approximately fourfold more DN
thymocytes on a per cell basis than that present
in normal thymus that gave high levels of
repopulation in adoptive recipients) suggests
that at a maximum, less than 1% of the DN
thymocytes in the severely involuted meV/me thy-
muses could have had precursor activity.
The DN thymocytes that are present in normal
mice, however, are composed of at least 11 differ-
ent subsets, each with different functional capa-
bilities and kinetics of thymocyte repopulation in
adoptive recipients (Scollay et al., 1988). Also
contained within these various thymocyte sub-
sets are DN thymocytes that express either CD3
or surface Ig and are unable to function as intra-
thymic precursors in adoptive transfer assay sys-
tems (Scollay et al., 1988). In addition, variations
in the DN CD3
/ population with respect to
mouse strains and to the class of T-cell receptor
expressed occurs (Shortman et al., 1990). Conse-
quently, we analyzed the DN thymocyte popu-
lation in the involuted thymuses to determine
whether there was an increase in the percentage
of DN cells expressing CD3 using the 2Cll
monoclonal antibody that detects a portion of the
CD3 complex expressed by both alpha/beta- and
gamma/delta-expressing T cells. An increase in
TABLE 6
Subpopulations of Double Negative (CD4-CD8-) Thymocytes in Involuted Thymuses
Animal age Thymus CD4-CD8- Percentage of CD4-CD8- thymocytes that are:
(months) cell number (x10-6) thymocytes
(%) CD3 or sIg CD3- sIg-
Untreated 173.3+10.4 3.9+_0.5 51 49
(1 month)
Untreated 73.3+_33.9 4.3+_0.5 51 49
(12 months)
Untreated 53.0 5.2 67 33
(18 months) 42.0 3.5 69 31
23.0 24.3 81 19
Stero d-treated 7.5+_4.1 23.8+_2.2 41 59
(1 month)
me"/me 270.0 4.1 30 70
(1 month) 150.0 4.5 20 80
13.0 14.0 49 51
Thymocytes from normal and involuted thymuses analyzed for expression of CD4, CD8, CD3, and surface Ig using two-color immunofluorescence staining (see
Materials and Methods). Data, unless otherwise marked, represent mean+standard deviations of three more.thymuses.
bDue to variability among single group, data given for individual thymuses.200 S.M. HAYES et al.
the proportion of DN CD3-expressing cells
would indicate an increase in the percentage of
CD4-CD8- thymocytes that would be unable to
generate thymocytes in adoptive recipients. We
have demonstrated that the involution process in
the meV/me mouse does not affect the relative
proportion of these cells in the DN subset (Table
6).
In light of our findings, it appears that the thy-
mic involution in meV/me mice may in part be
due to the CD4-CD8-CD3-sIg- subset being
unable to generate thymocytes, as demonstrated
by their transfer to adoptive recipients. To deter-
mine whether these precursors are arrested in
development, it will be of interest in future
studies to examine additional time points follow-
ing adoptive transfer of the donor thymocytes to
confirm the absence in involuted meV/me thy-
muses of each of the developmentally distinct
populations that have been described. However,
based on our inability to demonstrate any intra-
thymic precursor activity at day 14 following
transfer to irradiated recipients, and because of
the large excess of DN cells injected, it seems
highly unlikely that we have missed a significant
population of DN thymocytes in involuting
meV/me thymus that possesses precursor activity.
Alternatively, we have previously suggested
(Komschlies et al., 1987) that the bone marrow of
meV/me mice is deficient in an accessory cell (or
factor) that permits repopulation of the thymus
of irradiated recipients following i.v. adoptive
transfer. Addition of normal bone marrow to
meV/me bone marrow restores its i.v. thymus
repopulating capacity. Viable motheaten
(meV/mev) bone marrow (as are normal
thymocytes), however, is able to repopulate the
thymus of irradiated recipients following i.t.
injection without additional accessory cell (or
factor) requirements. It has been shown pre-
viously that a normal thymus contains a popu-
lation of bone marrow derived "accessory" den-
dritic cells of myeloid origin (Fowlkes and
Pardoll, 1989; Robey et al., 1990; Spangrude and
Scollay, 1990; von Boehmer, 1990) that are
important in the clonal selection, survival, and
differentiation of thymocytes (Robey et al., 1990;
von Boehmer, 1990). Codevelopment of such
myeloid stem cells following bone marrow i.t.
injection appears to be requisite for the sub-
sequent development of intrathymic precursors
and donor-origin thymocytes (Spangrude and
Scollay, 1990). Because numerous defects in
myeloid cells have been described in meV/me
mice in vivo and in vitro (McCoy et al., 1982, 1984;
Medlock et al., 1987; Hayashi et al., 1988; Shultz,
1988; Van Zant and Shultz, 1989), the lack of
these bone marrow derived dendritic cells in an
meV/me thymus may result in the absence, death,
and/or functional inactivity of meV/me intra-
thymic precursors. However, cell mixture exper-
iments of meV/me thymocytes with normal bone
marrow cells failed to "rescue" or provide evi-
dence for suppression of the thymus repopulat-
ing capacity of meV/me DN thymocytes following
i.t. adoptive transfer into irradiated recipients
(unpublished observations). These results sug-
gest that meV/me DN thymocytes, if they in fact
are intrathymic precursors, may be anergic to
such regulatory signals. It does not rule out,
however, that these positive signals may be
required only at specific, perhaps early, stages of
precursor development. The setup of our assay
system, in which "accessory" cells are not added
until thymic involution (hence loss of intra-
thymic precursor activity) has already occurred,
may be too late to rescue the intrathymic precur-
sor population.
It was also of interest in these studies to com-
pare the phenotypic and functional character-
istics of thymocytes in an involuting meV/me thy-
mus with other models of thymic involution in
an attempt to gain insight into the possible mech-
anisms involved. Thymic involution has been
observed in pregnancy, infection, surgery, drugs
(including cyclosporin A), steroids, malnutrition,
malignancy, and aging (Clarke and Kendall,
1989). Of special interest in our studies was the
involution in meV/me thymus with that of thy-
muses in aged mice, because we have suggested
previously (Medlock et al., 1986) that the meV/me
mouse may represent an accelerated model of
aging in the lymphopoietic system. Thymic
involution in normal mice begins soon after
puberty, while the animal is still increasing in
body weight (Santisteban, 1960). There is a
decrease in thymic weight with age, a loss of cor-
tical thymocytes, an increase of thymic adipose
tissue, and a general decrease in thymic function.
In addition, the thymic atrophy is reflected in the
peripheral tissues by a decrease in T-cell func-
tional responses, and an increase in a CD4
/
Pgp-1
/ population reflective of memory T cells
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As predicted, by 12 to 18 months of age, the
thymus cellularity in B6+/+ mice is reduced by
approximately 90% in comparison to that of
young (4-week-old) B6 mice. Our phenotypic
studies have demonstrated that in an involuting
aged thymus, essentially normal ratios of the
four phenotypic subsets of thymocytes are pre-
sent. Therefore, in the in vivo studies, equivalent
numbers of young and aged DN thymocytes
were injected into the recipient thymus. Even
though this is the case, the 17-month-old thymus
is severely deficient in intrathymic precursor
activity, and displays essentially no ability to
repopulate the thymus of irradiated recipients at
the cell doses examined (3-5106 cells injected).
One 18-month-old thymus, however, did exhibit
a variation in the proportions of the major thym-
ocyte subsets (24.3% DN, 43.6% DP, 32.1% SP).
When the DN thymocyte population was also
stained for CD3 or sIg, it was observed that in
this involuted thymus, 80% of the CD4-CD8- thy-
mocytes expressed either CD3 or Ig.
It appears, however, that the loss of intra-
thymic precursor activity with age in mice is not
due to a defect in the bone marrow prothymocyte
population. We found that on a per cell basis,
bone marrow from older mice is as efficient as
young marrow in thymus repopulating capacity.
Contradictory results exist in regards to the
study of the aging process and the immune sys-
tem. CFU-s activity’ and basal hemopoietic
activity do not appear to be affected by age
(Tyan, 1982; Williams et al., 1986). However,
other investigators find prothymocyte and thy-
mic activity to be impaired in aged mice (Kay,
1984; Hirokawa et al., 1986). We observed the
opposite; the defect is not readily apparent in the
thymus, as older irradiated recipients readily
supported the generation of donor-origin thymo-
cytes from both young and older marrow as well
as did younger irradiated recipients. It must be
cautioned that the irradiation model of repopu-
lation may not directly represent the in vivo situ-
ation in regard to thymus function. Thus,
irradiation may induce or reactivate "accessory
cells" or factors that promote thymocyte regener-
ation that are quiescent in intact aged host,s. For
example, an irradiated thymus may be induced
to secrete increased levels of chemotactic factors
(Harr et al., 1989) such as thymotaxin (Imhof et
al., 1988; Deugnier et al., 1989). However, it is
most likely not thymotaxin, because this com-
pound has been found to be beta-2 microglobulin
(Dargemont et al., 1989), and beta-2 microglobu-
lin-deficient mutants have normal development
of the thymus (Koller et al., 1990; Zijlstra et al.,
1990). Alternatively other, as yet undescribed,
factors may have a role in the irradiation induced
ability of thymus in aged mice to support thymo-
cyte production in the adoptive transfer system.
Similarly, we have provided evidence that the
thymic involution in meV/me mice is not due to
increased levels of steroids. Although essentially
all intrathymic precursor activity is eliminated by
a single dose of dexamethasone, we observed sig-
nificant differences in the phenotypic character-
istics of the remaining thymocyte populations.
Thus, in thymuses from steroid-treated mice, a
large proportion of the remaining lymphoid cells
were SP, and in thymuses from either meV/me or
aged mice, a much lower proportion of the
lymphoid cells were SP. The characteristics of the
thymocyte populations that were present follow-
ing steroid treatment were similar to those pre-
viously reported by numerous investigators
(Reichert et al., 1986; Vliet et al., 1986). Of interest
in this study was the unexpected finding of the
higher steroid sensitivity of intrathymic precur-
sors compared to bone marrow prothymocytes.
In the bone marrow, the prothymocyte popu-
lation is relatively resistant to steroids (Greiner et
al., 1982). We confirmed these findings, and we
were able to calculate that approximately 60% of
bone marrow prothymocyte activity is lost fol-
lowing steroid treatment. This is in marked con-
trast to the loss of intrathymic precursors
observed in the steroid-treated mice, in which
greater than 99% of the precursor activity was
lost. The loss of intrathymic precursor activity,
however, is supported by phenotyping data.
Approximately 40% of steroid-resistant DN thy-
mocytes express CD3 or Ig and would be unable
to generate thymocytes in adoptive recipients
(Table 6). Furthermore, other investigators have
shown that steroid treatment depletes CD5 thy-
mocytes (Scollay and Shortman, 1985), a popu-
lation that contains intrathymic precursor
activity (Fowlkes et al., 1985). Thus, although
steroids resulting from the stress induced by the
clinical symptoms of the autoimmune disease
process may contribute to the early thymic invol-
ution observed in meV/me mice, such contribution
is most likely a small and insignificant part of the
involution process.202 S.M. HAYES et al.
MATERIALS AND METHODS
Animals
Inbred C57BL/6J (Ly 5.2) and Ly 5 congenic
C57BL/6J-Ly 5.1 mice (hereafter referred to as B6
Ly5.2 and B6 Ly5.1, respectively) were purchased
from Charles River (Boston, MA) and Harlan
Sprague Dawley (Frederick, MD), respectively.
C57BL/6J-meV/me mice (hereafter referred to as
meV/me mice; Ly 5.2) were obtained from the col-
ony maintained at the Jackson Laboratory by
LDS. The inbred C57BL/6 mice are designated as
Ly 5.2; the congenic is designated by Ly 5.1
(SJL/J phenotype). This nomenclature is consist-
ent with that recently recommended by Morse et
al. (1987), and is opposite from the designation of
the monoclonal antibodies commercially avail-
able from Dupont/New England Nuclear. Unless
otherwise noted, animals were placed into exper-
iments when they were 4-6 weeks of age, and
were maintained on commercial chow and acidi-
fied chlorinated water ad libitum.
Antibodies
The unconjugated monoclonal antibodies
directed against the Ly 5.1 and Ly 5.2 alloanti-
gens were obtained from Dupont/New England
Nuclear (Boston, MA) and were developed for
immunofluorescen,ce analysis using an F(ab’)2
fragment of FITC-conjugated goat antimouse IgG
(heavy- and light-chain-specific) obtained from
Organon Teknika-Cappel (Malvern, PA). Mono-
clonal antibodies for use in the dual labeling
studies, FITC-conjugated antimouse Lyt-2 and
Phycoerythrin (PE)-conjugated antimouse L3T4,
were obtained from Becton Dickinson Immuno-
cytometry Systems, Mountain View, CA.
Dexamethasone-Resistant Thymocytes and
Bone Marrow Cells
Dexamethasone-resistant thymocytes and bone
marrow cells were obtained 48 h after i.p. injec-
tion of 0.5 mg of dexamethasone sodium phos-
phate (LyphoMed, Inc., Melrose Park, IL) into
4-6-week-old mice (Vliet et al., 1986; Compton et
al., 1987).
Cell Suspensions
Bone marrow cells were obtained by flushing
tibias and femurs with cold medium (Hepes
buffered RPMI 1640). After repeated gentle pipet-
ting to disperse the cells, the marrow was centri-
fuged at 150xg for 5 min and resuspended in cold
medium for cell counting. Thymus cell suspen-
sions were prepared by gently pressing the tis-
sues through a 50-mesh cell sieve followed by
washing in cold medium. Cell viability was
determined by exclusion of 0.1% trypan blue and
was greater than 95% in all cases (Greiner et al.,
1986).
Immunofluorescence Analysis
Thymocytes were labeled for immunofluor-
escence analysis as previously described
(Goldschneider, 1986). Briefly, a single-cell sus-
pension of thymocytes (lxl06/well) was added to
individual wells of 96-well U-bottom microtiter
plate and spun at 150xg for 2 min. The super-
natant was removed, the cells resuspended
directly in 10/1 of a saturating concentration of
the primary antibody (anti-Ly 5.1 or anti-Ly 5.2)
or medium (control) and incubated for 20 min at
4 C. The cells were spun at 150xg for 2 min, the
supernatant removed and the cells were washed
twice in cold medium containing 0.13% sodium
azide. After the last wash, the cells were resus-
pended directly in 10/1 of an appropriate
dilution of the developing antibody and incu-
bated for 20 min at 4 C. After the second incu-
bation, the cells were washed, fixed in buffered
formalin, and analyzed by flow microfluorimetry
for relative immunofluorescence on a FACS 4
(Becton-Dickinson Immunocytometry System,
Sunnyvale, CA). All viable nucleated cells were
gated for analysis, and dead cells and red blood
cells were excluded electronically. In two-color
analysis, thymocytes were incubated with FITC-
anti-Lyt 2 alone, with PE-anti-L3T4 alone, or sim-
ultaneously with both. In some cases, to exclude
the possible contribution of surface Ig
/ B cells in
the involuted thymuses in the calculation of
double negative (CD4-CD8-) thymocytes, anti-
CD4, anti-CD8, and FITC-conjugated goat anti-
mouse IgG were used to stain the thymocytes.
Irradiation
Recipients received the indicated level of whole
body irradiation from a 137Cs source (gamma cell
40 irradiator, Atomic Energy of Canada Limited,THYMOCYTOPOIESIS IN me"/me MICE’ 203
Ottawa, Canada) at a dose rate of approximately
95 rads/min 2-6 h prior to bone marrow cell
transfer (Greiner et al. 1986).
Intrathymic Adoptive Transfer,Assay System
Details of the intrathymic (i.t.) adoptive transfer
assay system for prothymocytes have been
described previously (Goldschneider et al., 1986;
Greiner et al., 1986; Komschlies et al., 1987;
Scollay et al., 1988). Briefly, irradiated (700 rad)
recipients received varying numbers of thymo-
cytes or bone marrow cells in 20/tl of media dis-
tributed equally between each thymus lobe (10
ill/lobe). Thirteen to fifteen days after thymocyte
transfer or 18 to 20 days after bone marrow cell
transfer, the thymus was removed, and the per-
centage and number of donor- and host-origin
cells were determined by immunofluorescence
analysis of Ly 5.1 (host) and Ly 5.2 (donor) bear-
ing thymocytes using flow microfluorimetry.
Intravenous Adoptive Transfer Assay System
This assay has been described in detail
(Goldschneider et al., 1986; Greiner et al., 1986;
Komschlies et al., 1987). Briefly, irradiated recipi-
ents (700 rad) were injected i.v. in the tail vein
with varying numbers of bone marrow cells (see
Results). Twenty to tw,enty-three days later, the
percentage and number of donor- (Ly 5.2+) and
host- (Ly 5.1 +) origin thymocytes were deter-
mined by immunofluorescence analysis using
flow microfluorimetry.
Calculation of Relative Intrathymic Precursor or
Bone Marrow Prothymocyte Activity
To calculate the relative intrathymic or pro-
thymocyte precursor activity of a donor thymus
or bone marrow when using either the i.t. or i.v.
adoptive transfer assay system, the following for-
mula was used:
Number of thymocytes generated from donor-origin cells
Cell dose
xdonor cell number=precursor activity
For example, if lx10 thymocytes injected from a
donor thymus that had 30xt0 cells generated 15
X106 donor-origin thymocytes in the adoptive
recipient, the total intrathymic precursor activity
of the donor thymus would be 450x106.
Calculation of Normalized Intrathymic
Precursor Activity
Once relative intrathymic precursor activity was
calculated for individual thymuses, the mean
(+standard deviation) intrathymic precursor
activity was calculated for the control thymuses.
The experimental thymus intrathymic precursor
activity was then normalized as a ratio of the
mean control thymus value.
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